The burden of coronary, cerebrovascular and peripheral arterial disease

PharmacoEconomics

Volumn 22, Issue SUPPL. 4, 2004, Pages 11-18

  Bakhai, Ameet ^a,b  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^b BARNET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTERY THROMBOSIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; CONFERENCE PAPER; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DEATH; DEMENTIA; DEVELOPED COUNTRY; DIAGNOSTIC ACCURACY; DISABILITY; ECONOMIC ASPECT; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH ECONOMICS; HEART INFARCTION; INTERMITTENT CLAUDICATION; LIFE EXPECTANCY; LONGEVITY; MORBIDITY; MORTALITY; NON INVASIVE MEASUREMENT; OUTCOMES RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STROKE; SURVIVAL; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; UNITED STATES; VASCULAR DISEASE; WORLD HEALTH ORGANIZATION;

CEREBROVASCULAR DISORDERS; CORONARY DISEASE; EVIDENCE-BASED MEDICINE; HEALTH CARE COSTS; HUMANS; LIFE EXPECTANCY; MORTALITY; PERIPHERAL VASCULAR DISEASES;

EID: 11244309816     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200422004-00004     Document Type: Conference Paper

References (36)

1. Drouet L. Atherothrombosis as a systemic disease. Cerebrovasc Dis 2002; 13 Suppl. 1: 1-6
2. Coccheri S. Distribution of symptomatic atherothrombosis and influence of atherosclerotic disease burden on risk of secondary ischaemic events: results from CAPRIE. Eur Heart J 1998; 19 Suppl. Abstract P1268
3. World Health Organization. The world health report 2004 - changing history. Geneva: World Health Organization; 2004
4. World Health Organization. The world health report 2003 - shaping the future. Geneva: World Health Organization; 2003
5. Guillot F, Moulard O. Epidemiological estimates of ischemic stroke and myocardial infarction. Circulation 1998; 98 Suppl. 1. Abstract 1421
6. American Heart Association. Heart disease and stroke statistics - 2004 update. Dallas, Texas: American Heart Association; 2003
7. Cairns J, Theroux P, Armstrong P, et al. Unstable angina - report from a Canadian expert roundtable. Can J Cardiol 1996; 12: 1279-92
8. Heidenreich PA, McClellan M. Trends in treatment and outcomes for acute myocardial infarction: 1975-1995. Am J Med 2001; 110: 165-74
9. Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002; 23: 1190-201
10. Collinson J, Flather MD, Fox KA, et al. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK). Eur Heart J 2000; 21: 1450-7
11. Taneja AK, Flather MD, Perez de Arenaza D, et al. Long-term follow up of acute coronary syndromes without ST elevation: PRAIS-UK [abstract]. Heart 2003; 89 Suppl. I: 22
12. World Health Organization. World Health Statistics Annual 2001. Geneva: World Health Organization; 2002
13. Goldberg RJ, Currie K, White K, et al. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol 2004; 93: 288-93
14. Kolominsky-Rabas PL, Sarti C, Heuschmann PU, et al. A prospective community-based study of stroke in Germany - the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months. Stroke 1998; 29: 2501-6
15. Giroud M, Milan C, Beuriat P, et al. Incidence and survival rates during a two-year period of intracerebral and subarachnoid haemorrhages, cortical infarcts, lacunes and transient ischaemic attacks. The Stroke Registry of Dijon: 1985-1989. Int J Epidemiol 1991; 20: 892-9
16. Wade PT. Stroke (acute cerebrovascular disease). In: Radcliffe Medical Press, editor. Health care needs assessment, the epidemiologically based needs assessment reviews. Oxford: Radcliffe Medical Press; 1994. pp. 121-255
17. Johnston SC, Gress DR, Browner WS, et al. Short-term prognosis after emergency department diagnosis of T1A. JAMA 2000; 284: 2901-6
18. Johnston SC. Clinical practice. Transient ischemic attack. N Engl J Med 2002; 347: 1687-92
19. Albers GW, Caplan LR, Easton JD, et al. Transient ischemic attack - proposal for a new definition. N Engl J Med 2002; 347: 1713-16
20. Johnston SC, Fayad PB, Gorelick PB, et al. Prevalence and knowledge of transient ischemic attack among US adults. Neurology 2003; 60: 1429-34
21. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation 1995; 91: 1472-9
22. Nicolaides AN, Delis K. Intermittent foot and calf compression: effects on arterial blood flow and value in treatment of intermittent claudication. Abstract presented at the 24th Annual Symposium on Current, Critical Problems, New Horizons and Techniques in Vascular and Endovascular Surgery. New York City, NY, November 1997
23. Belch JJ, Topol EJ, Agnelli G, et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003; 163: 884-92
24. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317-24
25. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381-6
26. Ouriel K. Peripheral arterial disease. Lancet 2001; 358: 1257-64
27. Murabito JM, Evans JC, Nieto K, et al. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 2002; 143: 961-5
28. Meijer WT, Hoes AW, Rutgers D, et al. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 1998; 18: 185-92
29. Hirsch AT, Halverson SL, Treat-Jacobson D, et al. The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care. Vasc Med 2001; 6: 87-96
30. Peeters A, Mamun AA, Willekens F, et al. A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort. Eur Heart J 2002; 23: 458-66
31. Caro JJ, Ishak KJ, Migliaccio-Walle K. Estimating survival for cost-effectiveness analyses: a case study in atherothrombosis. Value Health 2004; 7(5): 627-35
32. Levy E, Gabriel S, Dinet J. The comparative medical costs of atherothrombotic disease in European countries. Pharmacoeconomics 2003; 21: 651-9
33. Cohen DJ, Bakhai A, Shi C, et al. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses. Results from the sirolimus-eluting balloon expandable stent in the treatment of patients with de novo native coronary artery lesions (SIRIUS) Trial. Circulation 2004; 110: 508-14
34. Bakhai A, Flather MD, Collinson JR, et al. National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United Kingdom. Int J Cardiol 2003; 91: 163-72
35. Centers for Medicare and Medicaid Services. National Health Expenditure 2001. Baltimore: Centers for Medicare and Medicaid Services. Available at www.cms.hhs.gov/statistics/nhe/historical/t3.asp [Accessed Dec 19 2003]
36. Bakhai A, Dabbous OH, Cohen DJ, et al. Inter-hospital transfers are costly, cause delays and do not address the imbalance of access to revascularization: the case for more angiographic facilities? Results from the Global Registry of Acute Coronary Events [abstract]. J Am Coll Cardiol 2004; 43 Suppl. A: 1040-71